NDC product
mycophenolic acid
NDC 68254-5001 · CONCORD BIOTECH LIMITED
Key facts
| Product NDC | 68254-5001 |
|---|---|
| Proprietary name | mycophenolic acid |
| Nonproprietary name | mycophenolic acid |
| Substances | MYCOPHENOLATE SODIUM |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Labeler | CONCORD BIOTECH LIMITED |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA211173 |
| Pharmacologic classes | Antimetabolite Immunosuppressant [EPC] |
| Marketing start | Dec 13, 2019 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: